Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
89,401,055
-
Shares change
-
+12,407,922
-
Total reported value, excl. options
-
$1,831,770,744
-
Value change
-
+$255,347,743
-
Put/Call ratio
-
13%
-
Number of buys
-
104
-
Number of sells
-
60
-
Price
-
$20.49
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q3 2023
As of 30 Sep 2023 ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) had 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 89,401,055 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, MAVERICK CAPITAL LTD, BlackRock Inc., VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, STATE STREET CORP, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and Logos Global Management LP.
This table shows 174 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.